Skip to main content

MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

27 Jul 2023 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended June 2023. The figure stood at Rs. 0.00 millions during the year-ago period.The Total Profit for the quarter ended June 2023 of Rs. 3.76 millions grew from Rs.-5.01 millions Operating profit Margin for the quarter ended June 2023 improved to 3.78% as compared to -4.98% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 4.29 -3.85 -211.43 4.29 -3.85 -211.43 2.95 7.89 -62.61
PBIDT 3.78 -4.98 -175.90 3.78 -4.98 -175.90 0.86 3.84 -77.60
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 3.78 -4.98 -175.90 3.78 -4.98 -175.90 0.86 3.84 -77.60
Depreciation 0.02 0.03 -33.33 0.02 0.03 -33.33 0.13 0.19 -31.58
PBT 3.76 -5.01 -175.05 3.76 -5.01 -175.05 0.73 3.65 -80.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.26 -1.95 -113.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.04 -0.30 246.67
PAT 3.76 -5.01 -175.05 3.76 -5.01 -175.05 0.47 5.60 -91.61
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1878.65
Dr. Reddys Labs. 1386.05
Cipla 1394.30
Lupin 1987.60
Zydus Lifesciences 1200.25
View more..